The proportion of the M-MDSCs (HLA-DR-CD11b+CD33hiCD14+) and PMN-MDSCs (HLA-DR-CD11b+CD33low CD15+) in the peripheral blood of liver cancer patients was significantly increased (P<0.01, Figure 7A). Here, FUT4 is linked to liver cancer.